Literature DB >> 9041306

Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer.

C G Prober1, E E Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041306     DOI: 10.1542/peds.99.3.472

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Evaluation of two rapid detection assays for identification of respiratory syncytial virus in nasopharyngeal secretions of young children.

Authors:  C Wyder-Westh; A Duppenthaler; M Gorgievski-Hrisoho; C Aebi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-08       Impact factor: 3.267

2.  Respiratory syncytial virus immune globulin intravenous.

Authors: 
Journal:  Paediatr Child Health       Date:  1998-01       Impact factor: 2.253

Review 3.  Eosinophils, ribonucleases and host defense: solving the puzzle.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 4.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response.

Authors:  J S Sandhu; S F Krasnyanski; L L Domier; S S Korban; M D Osadjan; D E Buetow
Journal:  Transgenic Res       Date:  2000-04       Impact factor: 2.788

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 7.  Biochemical prevention and treatment of viral infections - a new paradigm in medicine for infectious diseases.

Authors:  Hervé Le Calvez; Mang Yu; Fang Fang
Journal:  Virol J       Date:  2004-11-23       Impact factor: 4.099

8.  Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.

Authors:  Ahmad Abushahin; Ibrahim Janahi; Amjad Tuffaha
Journal:  Int J Gen Med       Date:  2018-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.